CD63 (F8P5K) Rabbit Monoclonal Antibody and 3 more items

The University of Nebraska Medical Center (UNMC), a state agency operating under the University of Nebraska system, awarded a Purchase Order (PO) valued at $1,521.00 to Cell Signaling Technology Inc., a Boston, Massachusetts-based vendor. The contract, executed on July 28, 2026, with a completion date of August 4, 2026, covers the procurement of four rabbit monoclonal antibody products for delivery to UNMC General Supply in Omaha, Nebraska. The purchase order is governed by the Standard Terms of Purchase established by the Board of Regents of the University of Nebraska and is processed through the ARIBA Procure-to-Pay system. Payment terms are established at Net 30, with freight prepaid on a Free On Board destination basis.

The line items procured include four distinct antibody products: CD63 (F8P5K) Rabbit Monoclonal Antibody ($376.00), CD81 (D5O2Q) Rabbit Monoclonal Antibody ($348.00), Akt (pan) (C67E7) Rabbit Monoclonal Antibody ($351.00), and Phospho-Akt (Ser473) (D9E) Rabbit Monoclonal Antibody ($446.00). Each item is ordered as a single unit. The vendor is required to acknowledge acceptance of the purchase order within 10 days of issuance and complete delivery by August 4, 2026, supporting the medical research and diagnostic capabilities of the University of Nebraska Medical Center.